AVBP

ArriVent BioPharma, Inc.

Healthcare · Biotechnology

15.10$ -47.0% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AVBP
Line item	2021	2022	2023	2024	2025
Revenue	–	0.00	0.00	0.00	0.00
Research & Development	5.04	0.91	2.03	2.51	3.99
Selling, General & Administrative	2.36	0.19	0.30	0.49	0.63
Total Operating Expenses	6.81	1.10	2.33	3.00	4.62
Operating Income	-6.81	-1.10	-2.33	-3.00	-4.62
Pre-Tax Income	-40.44	-1.10	-2.17	-2.56	-4.32
Income Tax Expense	-9.08	-1.10	–	-2.56	–
Net Income	-40.44	-1.10	-2.17	-2.56	-4.32
EBITDA	-40.44	-1.10	-2.17	-2.56	-4.32

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.